J024 Predictors of medication discrepancies in Huntington’s disease: patient self-report compared to pharmacy records

<h3>Background</h3> Proper medication reconciliation (= comparing the accuracy of patient-reported medication use with pharmacy records) could prevent potentially dangerous situations such as drug-drug interactions and hospitalization. This is particularly important when patients rely on multiple medications and may suffer from cognitive impairment, such as in neurodegenerative disorders like Huntington’s Disease (HD). Currently, it is unknown how often medication discrepancies occur in HD patients and which factors contribute to the discrepancies. <h3>Aims</h3> Identify prognostic factors of medication discrepancies in HD, using patient-reported medication use and local pharmacy records. <h3>Methods</h3> With 134 pre- and manifest HD patients, we performed a multivariable logistic regression analysis with medication discrepancy as dependent variable (pharmacy records as reference value) and sex, CAP score, disease status (pre- or manifest HD), number of concomitant medications taken, presence of an informal caregiver, Unified Huntington’s Disease Rating Scale-Total Functioning Capacity, unified cognitive Z-score and Problem Behaviors Assessment-short characteristic scores for depression, anxiety, and apathy as independent variables. <h3>Results</h3> Medication discrepancies were reported frequently, both in premanifest (42.2%) and manifest HD subjects (37.1%). Impaired cognition significantly predicted medication discrepancies (beta = -0.663, SE 0.27, p = 0.014). All other variables were non-significant. <h3>Conclusions</h3> Regardless of HD disease status and stage, patient self-reported medication use is not a reliable source, especially in those with impaired cognitive function. The presence of an informal caregiver and the absence of polypharmacy, depression, anxiety and apathy do not influence self-reported medication accuracy. Objective verification of medication use with HD patients’ local pharmacy is recommended.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.345
Primary Topic
Parkinson's Disease and Spinal Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

J024 Predictors of medication discrepancies in Huntington’s disease: patient self-report compared to pharmacy records

Stephanie Feleus, Susanne de Bot, Laura C M Kuijper, Raymund A.C. Roos et al.
Parkinson's Disease and Spinal Disorders
article

J024 Predictors of medication discrepancies in Huntington’s disease: patient self-report compared to pharmacy records

Stephanie Feleus, Susanne de Bot, Laura C M Kuijper, Raymund A.C. Roos, Mai-Ly T D Vo
article en

Abstract

<h3>Background</h3> Proper medication reconciliation (= comparing the accuracy of patient-reported medication use with pharmacy records) could prevent potentially dangerous situations such as drug-drug interactions and hospitalization. This is particularly important when patients rely on multiple medications and may suffer from cognitive impairment, such as in neurodegenerative disorders like Huntington’s Disease (HD). Currently, it is unknown how often medication discrepancies occur in HD patients and which factors contribute to the discrepancies. <h3>Aims</h3> Identify prognostic factors of medication discrepancies in HD, using patient-reported medication use and local pharmacy records. <h3>Methods</h3> With 134 pre- and manifest HD patients, we performed a multivariable logistic regression analysis with medication discrepancy as dependent variable (pharmacy records as reference value) and sex, CAP score, disease status (pre- or manifest HD), number of concomitant medications taken, presence of an informal caregiver, Unified Huntington’s Disease Rating Scale-Total Functioning Capacity, unified cognitive Z-score and Problem Behaviors Assessment-short characteristic scores for depression, anxiety, and apathy as independent variables. <h3>Results</h3> Medication discrepancies were reported frequently, both in premanifest (42.2%) and manifest HD subjects (37.1%). Impaired cognition significantly predicted medication discrepancies (beta = -0.663, SE 0.27, p = 0.014). All other variables were non-significant. <h3>Conclusions</h3> Regardless of HD disease status and stage, patient self-reported medication use is not a reliable source, especially in those with impaired cognitive function. The presence of an informal caregiver and the absence of polypharmacy, depression, anxiety and apathy do not influence self-reported medication accuracy. Objective verification of medication use with HD patients’ local pharmacy is recommended.

Leiden University Medical Center (NL), Stichting Epilepsie Instellingen Nederland (NL)
Openalex Percentile: Top 76%
Parkinson's Disease and Spinal Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.